Huang Li-Hua, Xu Hong-De, Yao Zhen-Yu, Wang Yan-Guang, Liu Hong-Min
College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou 450001, China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; New Drug Research & Development Center, Zhengzhou University, Zhengzhou 450001, China.
School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; New Drug Research & Development Center, Zhengzhou University, Zhengzhou 450001, China.
Bioorg Med Chem Lett. 2014 Feb 1;24(3):973-5. doi: 10.1016/j.bmcl.2013.12.056. Epub 2013 Dec 19.
Novel C6-amino substituted purine nucleoside analogues (2-12) bearing a modified pyranose-like D ring of the 4-azasteroid moiety were efficiently synthesized through nucleophilic substitution at C6 position of the steroidal nucleoside precursors (1a, b) with versatile amines. All the synthesized new compounds were evaluated for their anticancer activity in vitro against Hela, PC-3 and MCF-7 cell lines. Among them, compounds 4b, 7b and 9b exhibited significant cytotoxicity with the IC50 values of 2.99 μM (PC-3), 2.84 μM, (PC-3) and 2.69 μM (Hela), respectively.
通过甾体核苷前体(1a,b)的C6位与多种胺进行亲核取代反应,高效合成了带有修饰的4-氮杂甾体部分吡喃糖样D环的新型C6-氨基取代嘌呤核苷类似物(2-12)。对所有合成的新化合物进行了体外抗Hela、PC-3和MCF-7细胞系的抗癌活性评估。其中,化合物4b、7b和9b表现出显著的细胞毒性,IC50值分别为2.99 μM(PC-3)、2.84 μM(PC-3)和2.69 μM(Hela)。